Home » Blog » Global Clinical Trials Forum

Global Clinical Trials Forum

By Amigos IAS

Why is it in the news?

  • The first WHO Global Clinical Trials Forum took place on November 20-21, 2023.
  • Around 130 experts from 43 countries participated, representing a diverse range of perspectives and experiences in clinical research.

 More about the news

  • The forum aimed to bring together global experts to discuss and develop a comprehensive and sustainable vision for clinical research infrastructure.
  • The primary goal was to enhance the capacity and capabilities of clinical research on a global scale.
  • The discussions and initiatives were focused on aligning with the World Health Assembly resolution, ensuring that global clinical trials contribute effectively to public health goals.
  • A key focus was on improving the quality and coordination of clinical trials, aiming for standardized practices and enhanced collaboration among researchers worldwide.
Clinical Trials

·       Clinical trials are research studies designed to evaluate the safety and efficacy of medical treatments, interventions, or drugs in humans.

·       These trials gather essential data on the effectiveness and potential side effects of new or existing treatments.

·       The outcomes of clinical trials contribute significantly to the development of evidence-based medical practices, guiding healthcare decisions and treatment approaches.


Clinical Trials Registry – India (CTRI)

·       The Clinical Trials Registry – India (CTRI) was established in 2007.

·       It is maintained by the Indian Council of Medical Research (ICMR) under the Ministry of Health and Family Welfare.

·       Every clinical trial conducted in India is required to be registered with CTRI before commencing.

·       CTRI serves as a free online public record system for the registration of clinical trials, encompassing both public and private research initiatives.


Amendment to New Drugs and Clinical Trial Rules (2023)

·       In June, the government passed an amendment to the New Drugs and Clinical Trial Rules (2023).

·       The amendment permits researchers to utilize non-animal and human-relevant methods for testing the safety and effectiveness of new drugs. This aligns with global trends toward ethical and efficient research practices.

Signup for newsletter

Receive notifications straight into your inbox

Leave a comment

Item added to cart.
0 items - 0.00

Discover more from AMIGOS IAS

Subscribe now to keep reading and get access to the full archive.

Continue reading